Table 3.
Risk-of-bias (RoB) assessment based on the revised Cochrane RoB tool for randomized trials (RoB 2.0).a
| Study, year | Randomization biasb | Deviation biasc | Missing data biasd | Measurement biase | Selection biasf | Overall |
| Direito et al [69], 2015 | + | + | + | + | + | + |
| Edney et al [66], 2020 | + | + | + | + | + | + |
| Fanning et al [57], 2017 | ? | ? | ? | + | ? | − |
| Fukuoka et al [58], 2019 | + | + | + | + | + | + |
| Garcia-Ortiz et al [73], 2018 | + | ? | ? | + | + | ? |
| Garde et al [74], 2018 | + | ? | ? | + | ? | − |
| Glynn et al [75], 2014 | ? | + | + | + | + | ? |
| Gremaud et al [59], 2018 | + | ? | + | + | ? | ? |
| Harries et al [76], 2016 | ? | ? | + | + | ? | − |
| Hurkmans et al [77], 2018 | − | ? | + | + | + | − |
| King et al [60], 2016 | + | + | + | + | ? | ? |
| Kitagawa et al [70], 2020 | ? | + | + | + | ? | ? |
| Leinonen et al [72], 2017 | + | − | − | + | + | − |
| Lyons et al [61], 2017 | + | + | + | + | + | + |
| Martin et al [56], 2015 | + | + | + | + | ? | ? |
| Pope and Gao [62], 2020 | − | ? | + | + | ? | − |
| Recio-Rodriguez et al [78], 2016 | + | ? | ? | + | + | ? |
| Robertson et al [67], 2018 | + | − | − | + | ? | − |
| Schade et al [63], 2020 | ? | ? | − | + | ? | − |
| Simons et al [68], 2018 | − | ? | + | + | ? | − |
| Walsh et al [71], 2016 | + | + | + | + | ? | ? |
| Zhang, and Jemmott [64], 2019 | + | ? | + | + | ? | ? |
| Zhou et al [65], 2018 | + | + | + | + | ? | ? |
a+ = low risk of bias; ?=some concerns; −=high risk of bias.
bBias arising from the randomization process.
cBias because of deviations from the intended intervention.
dBias because of missing outcome data.
eBias because of measurement tools used to collect outcome data.
fBias in selection of the reported result.